中国中药(00570.HK)主席变更

阿斯达克财经
30 Sep 2024

中国中药(00570.HK) 公布,董事会于9月27日作出决议,因其工作内容调整,陈映龙不再担任执行董事及董事会主席,有关安排即时生效。自他辞任执行董事生效后,亦不再担任董事会提名委员会“提名委员会”及战略委员会“战略委员会”主席职位,并不再代行总裁职务。
公司指,于同日,杨军和李鸿坚已获委任为执行董事,董事会亦已选举杨军担任董事会主席,并委任李鸿坚为总裁。(ha/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-09-27 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10